A selective intracellular free radical generation strategy against cancer cells is developed by lysosomal bioactivation of a prodrug/procatalyst co-delivery nanosystem.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: